Solar-powered device affordable, reliable tool to measure blood pressure
American Heart Association rapid access journal report
2010-11-09
(Press-News.org) A new solar-powered device to measure blood pressure may help slow the worldwide increase in cardiovascular disease by providing affordable and reliable blood pressure testing in low income countries, according to research published in Hypertension: Journal of the American Heart Association.
The solar powered device — 94 percent in agreement with the standard blood pressure testing method for systolic blood pressure — is in field testing in Uganda and Zambia, Africa.
"The incidence of hypertension is rising dramatically in these countries," said Eoin O'Brien, M.D., lead author of the study and professor in Conway Institute of Biomolecular and Biomedical Research at the University College Dublin in Belfield, Dublin, Ireland. "Hypertension leads to stroke and heart attack as the major cause of death around the world. It is greater than malnutrition, cancer and AIDS."
Many low-income countries have a short supply of trained medical personnel, he said. "We have been able to provide an accurate, robust and inexpensive device to diagnose high blood pressure. It's a start. If we can't measure blood pressure, we certainly can't begin to treat hypertension."
The World Health Organization asked multiple companies to devise a blood pressure measuring device that was accurate, easy to use and solar powered. One device met their criteria. After initial testing showed the accuracy of the selected device, it was used in two centers in Uganda and one center in Zambia. Staff, trained on the fully automated device in about 15 minutes, took blood pressure readings on about 716 participants, using the new device and a standard one. They repeated the effort one month later. Both patients and healthcare professionals preferred the new device:
Eighty-five percent of healthcare professionals rated the solar device as good or very good primarily because of ease of use (88 percent) and the automated features (85 percent).
Seventy-nine percent considered the solar device an advantage over the standard device.
The majority of healthcare providers rated it best for its comfort, clearly legible readings, the cuff and the on/off switch.
After the first and final visit a month later for patient blood pressure readings, 97 percent of healthcare professionals favored the new device and would recommend its use.
"Solar energy eliminates the need for expensive rechargeable batteries in remote areas where electricity and the availability of batteries might be scarce, but sunlight is plentiful," O'Brien said. "It can be run on batteries, but it can also be left in the sunlight to charge, making it ideal for rural areas and use out in the bush."
The device costs about $32 (25 Euro), with significant savings from not having to provide and use batteries regularly, he said.
While the device initially fulfilled accuracy criteria for the European Society of Hypertension, it had less accuracy for diastolic blood pressure (the pressure when the heart relaxes) on a second testing and in the study. But it wouldn't be difficult for manufacturers to correct the device, O'Brien said. Moreover, systolic blood pressure (the pressure when the heart contracts) is the major contributor to cardiovascular events. "Systolic blood pressure is the blood pressure reading on which most decisions are made," O'Brien said.
Manufacturers of other devices, such as those used to record or measure blood sugar, cholesterol and electrocardiograms (ECG), might also be encouraged to fulfill the requirements of low income countries, he said. "We now hope to use the solar device to diagnose hypertension in pregnancy as a step towards reducing the very high maternal death rates from this illness in low income countries."
INFORMATION:
Co-authors are: Gianfranco Parati, M.D.; Michael Ochan Kilama, M.D.; Andrea Faini, M.D.; Elisa Facelli, M.D.; Kenneth Ochen, M.D.; Cyprian Opira, M.D.; Shanthi Mendis, M.D.; Jiguang Wang, M.D.; and Neil Atkins, Ph.D. Author disclosures are on the abstract.
The World Health Organization funded the study.
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.americanheart.org/corporatefunding.
NR10-1164 (Hypertension10/O'Brien)
Editor's Note:
Visit the American Heart Association's high blood pressure Web site – www.heart.org/hbp - to learn more about high blood pressure risk factors, treatment options, side effects and success rates.
Additional resources:
Downloadable stock footage, animation, and our image gallery are located at www.heart.org/news under Multimedia.
Stay up to date on the latest news from American Heart Association scientific meetings, including Scientific Sessions 2010, by following us at www.twitter.com/heartnews. We will be tweeting from the conference using hashtag #AHA10News.
ELSE PRESS RELEASES FROM THIS DATE:
2010-11-09
A small study suggests women with multiple sclerosis have lower vitamin D levels during pregnancy and breastfeeding, according to a report posted online today that will appear in the March 2011 print issue of Archives of Neurology, one of the JAMA/Archives journals. However, these vitamin D levels were not associated with a greater risk of multiple sclerosis relapse after childbirth.
"During the last decade, low level of vitamin D, a potent immunomodulator, has emerged as an important risk factor for multiple sclerosis (MS) as well as other autoimmune diseases and certain ...
2010-11-09
Chemists at UC San Diego have uncovered a new chemical reaction on tiny particulates in the atmosphere that could allow scientists to gain a glimpse from ancient rocks of what the atmospheres of the Earth and Mars were like hundreds of millions years ago.
Their discovery also provides a simple chemical explanation for the unusual carbonate inclusions found in a meteorite from Mars that was once thought by some scientists to be evidence of ancient Martian life.
"We never knew before how the atmosphere could be trapped in carbonate," said Mark Thiemens, dean of UC San ...
2010-11-09
Philadelphia – November 8, 2010 – New research shows a gene-based test for lung cancer risk assessment motivates smokers to quit or cut down, according to results of a clinical study presented today at the American Association of Cancer Research's Ninth Annual Conference on Frontiers in Cancer Prevention Research.
Six months after taking the Respiragene test to identify susceptibility for lung cancer risk, 32% of the randomly recruited smokers in the study had quit smoking altogether and a further 48% had reduced their intake of cigarettes. More than half of the smokers ...
2010-11-09
CAMBRIDGE, Mass. -- Suppressing cancer cells' ability to replicate damaged DNA could dramatically enhance the effectiveness of chemotherapy drugs such as cisplatin, according to a new pair of papers from MIT biologists.
In studies of mice, the researchers found that slowing down a specific system for tolerating DNA damage not only prolonged survival but also prevented relapsed tumors from becoming resistant to chemotherapy, and made tumors much less likely to spread to other parts of the body.
Two enzymes that play key roles in a cell's response to DNA damage could ...
2010-11-09
New Orleans, LA – Research led by Dr. Nicolas Bazan, Boyd Professor, Villere Chair, and Director of the Neuroscience Center of Excellence at LSU Health Sciences Center, has shown that Docosahexaenoic acid (DHA), a component of fish oil, is a powerful therapeutic agent that can protect brain tissue and promote recovery in an experimental model of acute ischemic stroke, even when treatment is delayed by up to five hours. These findings not only target a new stroke treatment approach, but also provide vital information about the length of the therapeutic window. The NIH-funded ...
2010-11-09
The preservation of a protein found in particular synapses in the brain plays a key role in protecting against vascular dementia after a stroke, say researchers at King's College London.
The study, funded by the Dunhill Medical Trust, is published today in the 9 November issue of Neurology, the medical journal of the American Academy of Neurology. Researchers say the study findings increase understanding of vascular dementia, and highlight a possible target for future diagnoses and treatment of the condition.
Professor Paul Francis, King's College London, said: 'Vascular ...
2010-11-09
Jerusalem, November 8, 2010 – Research carried out in Mali, West Africa, has demonstrated that a new, safe and uncomplicated insect control method, developed at the Hebrew University of Jerusalem, can bring about a serious decline in malaria-bearing mosquitoes in afflicted regions in the world.
The research in Africa was based on work carried out earlier in Israel by researchers at the Kuvin Center for the Study of Tropical and Infectious Diseases at the Hebrew University of Jerusalem that showed how attractants of plant origin (fruit or flowers) with a toxic sugar bait ...
2010-11-09
Scientists have found that the fat cells and tissues of morbidly obese people and animals can reach a limit in their ability to store fat appropriately. Beyond this limit several biological processes conspire to prevent further expansion of fat tissue and in the process may trigger other health problems.
Research funded by the Biotechnology and Biological Sciences Research Council (BBSRC), the Medical Research Council (MRC) and the European Union Sixth Framework Programme, shows that a protein called secreted frizzled-related protein 1 (SFRP1) is produced by fat cells ...
2010-11-09
Do you like to do good things for other people? If so, your genes might be responsible for this. At least, the results of a study conducted by researchers of the University of Bonn suggest this. According to the study, a minute change in a particular gene is associated with a significantly higher willingness to donate. People with this change gave twice as much money on average to a charitable cause as did other study subjects. The results have now been published in the journal Social Cognitive & Affective Neuroscience (doi: 10.1093/scan/nsq083).
The researchers working ...
2010-11-09
Researchers from the Niels Bohr Institute at the University of Copenhagen have succeeded in storing quantum information using two 'entangled' light beams. Quantum memory or information storage is a necessary element of future quantum communication networks. The new findings are published in Nature Physics.
Quantum networks will be able to protect the security of information better than the current conventional communication networks. The cornerstone of quantum communication is a phenomenon called entanglement between two quantum systems, for example, two light beams. ...
LAST 30 PRESS RELEASES:
[Press-News.org] Solar-powered device affordable, reliable tool to measure blood pressure
American Heart Association rapid access journal report
